Extracellular matrix in cancer progression and therapy is a research paper published in Medical Review (2022). On theSindex it has a DataRank of 0.587. It has been cited 49 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.587
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 1R01EY028450
National Institutes of Health
Grant: R01CA201340
NEI NIH HHS
Grant: R01 EY028450
National Institutes of Health
Grant: 5R01CA201340-04
Defining Early Escape Strategies in LKB1 Mutant Lung Cancer
National Institutes of Health
Grant: 5R01EY028450-02
The RPE and Recovery of the Blood Retina Barrier
Fields of Study
Keywords
Additional file 1 of The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes?
Additional file 1 of The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes?